Catalyst Wire Dossier Catalyst Wire Dossier

Crofelemer

crofelemer · Napo Therapeutics, S.p.A.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Crofelemer, covering 2019-11-25 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) [Phase 2, Phase 3]

See pricing